SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-095486
Filing Date
2024-08-12
Accepted
2024-08-12 16:30:08
Documents
11
Period of Report
2024-08-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K stro-20240808.htm   iXBRL 8-K 38983
  Complete submission text file 0000950170-24-095486.txt   152379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240808.xsd EX-101.SCH 26371
13 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240808_htm.xml XML 4527
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 241197187
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)